I know it's hard to do. Afterall, Most posting on here , bought to sell later at a profit.
I say most, as we know full well there are a few shorting.
Want to make some decent $$$ ?
The day will come, when we wake up to a morning press release, That being a buyout or business partner for the MBc trial.
A few interesting things very recently.
1. The investors presentation, PDF has been updated, for October.
My recommendation, give it a resd.
The overall feel is that of strong confidence in the MOA.
The clinical details of the trials, very well explained.
Missing? Very obvious lack of mention of any potential business development.
Previously they had 2 slides talking directly about.business development initiatives.
For many years always a side note regarding licensing inside & outside of America.
Now? Not a peep.
2. The press release a few weeks ago, Was a very strong statement. Notably they in writing discussed the accelerated approval option.
If nothing else, take the time , read & understand the October presentation.
The business development?
They must have a partner to proceed with the MBc trial.
Why remove the licensing statements.?
folks can speculate from here to the moon & back.
both positive & negative rationales.
Truth ..l,we will know when things are announced. Not before.
stay tuned.
BTW , I would enjoy reading some specific comments about the investor presentation.
afterall, this is a biotech development company, talking about their developments.
My opinion. Much of the value is in the early slides.
they explain in general what Pela is.
the later slides explain how it works.
as well as potential sales opportunities.